
05
May
Climate change poses a fundamental threat to our livelihood and addressing the crisis through the reduction of carbon pollution is vital. The National Health Service (NHS) in the UK has committed to reducing the carbon footprint from inhaler devices by 50% by 2030, primarily through a reduction in the use of pressurised metered-dose inhalers (pMDI). The development of pMDIs utilising lower global warming potential propellants by 2025 is currently underway. This article focuses on the need to apply an individualised approach for patient outcomes whilst minimising the carbon footprint of their inhaler treatments.

26
Apr
EMJ Hepatology 10 [Supplement 2] 2022
This article highlights a poster presented at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting® Digital Experience congress and summarises a symposium session from the North American Society for Pediatric Gastroenterology…

22
Apr
EMJ Urology 10 [Supplement 1] 2022
The use of prostate artery embolisation (PAE), a minimally invasive alternative to surgical treatment options, is explored in this review article, which offers an extensive overview of different management regimens and treatment approaches for benign prostatic hyperplasia (BPH).

12
Apr
EMJ Oncology 10 [Supplement 7] 2022
EMJ had the pleasure of interviewing leading specialists in the field of breast cancer: Javier Cortés, International Breast Cancer Center, Quiron Group, Barcelona, Spain, and Giuseppe Curigliano, European Institute of Oncology (IEO), Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rionero in Vulture, and University of Milano, Milan, Italy
![EMJ Neurology 10 [Infographic Supplement 1] 2022 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/EMJ-Neurology-10-Infographic-Supplement-1-2022-Feature-Image-940x649.jpg)
29
Mar
EMJ Neurology 10 [Infographic 1] 2022
This infographic explores depression in patients with epilepsy, focusing on the impact of the COVID-19 pandemic. Questioning what healthcare professionals can do to help, this infographic analyses the epidemiology of depression and notes the differences between patients with controlled epilepsy and those with drug-resistant epilepsy.

22
Mar
EMJ Hematology 10 [Supplement 4] 2022
Myelodysplastic syndromes (MDS) are a rare group of blood disorders that can result in symptoms spanning from fatigue to easy bruising and bleeding. Based on a symposium that was part of the International Congress on Myelodysplastic Syndromes by the MDS Foundation, this article provides an overview of MDS.
![EMJ Oncology 10 [Supplement 6] 2022 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/EMJ-Oncology-10-Supplement-6-2022-Feature-Image-940x563.jpg)
21
Mar
EMJ Oncology 10 [Supplement 6] 2022
Using a co-ordinated multidisciplinary team (MDT) of healthcare professionals is an effective approach in managing the treatment of patients with cancer, providing tailored support, and improving patient outcomes. This collaborative approach promotes shared decision-making and adaptive strategies, and enables individualised patient care. In this review article, the author reflects on the latest advancements in the MDT approach to cancer care shared at the European Society for Medical Oncology (ESMO) Congress 2021.
Loading posts...